Repurposed arthritis drug did not significantly improve severe COVID-19 pneumonia ...Middle East

A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality rate at 28 days for participants who received it compared to a placebo.

Hence then, the article about repurposed arthritis drug did not significantly improve severe covid 19 pneumonia was published today ( Tuesday 02/03/2021 - 01:34 AM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Repurposed arthritis drug did not significantly improve severe COVID-19 pneumonia )

Also on site :

• Your spend as a ‘weapon’: Scott Galloway’s ‘Resist and Unsubscribe’ movement asks you to ditch Amazon, Apple, and Netflix to oppose Trump
• Iran strikes US military base in Bahrain as explosions heard across Gulf
• 'Any Updates?' Chuck Schumer's Post Last Year Accusing Trump of Being Weak on Iran Has Aged Wonderfully